Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 15.25
-2.74 %
$ 1.39 B
Market Cap
-11.91
P/E
INCOME STATEMENT
678 M
REVENUE
-124 M
OPERATING INCOME
-112 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Myriad Genetics, Inc.
| Revenue | 678 M |
| Cost Of Revenue | 202 M |
| Gross Profit | 476 M |
| Operating Expenses | 600 M |
| Operating Income | -124 M |
| Other Expenses | -11.7 M |
| Net Income | -112 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 | Jun-2011 | Jun-2010 | Jun-2009 | Jun-2008 | Jun-2007 | Jun-2006 | Jun-2005 | Jun-2004 | Jun-2003 | Jun-2002 | Jun-2001 | Jun-2000 | Jun-1999 | Jun-1998 | Jun-1997 | Jun-1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||||
| Revenue | 678.4 | 690.6 | 557.0 | 851.1 | 851.1 | 772.6 | 771.4 | 753.8 | 723.1 | 778.2 | 613.2 | 496.0 | 402.1 | 362.6 | 326.5 | 333.6 | 157.1 | 114.3 | 82.4 | 56.6 | 64.3 | 53.8 | 45.2 | 34.0 | 25.3 | 23.2 | 15.2 | 6.6 |
| GROSS PROFIT | ||||||||||||||||||||||||||||
| Cost Of Revenue | 202.0 | 197.6 | 178.2 | 201.0 | 201.0 | 177.2 | 171.2 | 157.3 | 147.4 | 109.2 | 79.6 | 64.7 | 46.7 | 44.3 | 43.3 | 32.3 | 30.8 | 27.6 | 20.3 | 13.8 | 12.6 | 10.7 | 7.4 | 0.7 | 100 K | (1.9) | (2.2) | (1.6) |
| Gross Profit | 476.4 | 493.0 | 378.8 | 650.1 | 650.1 | 595.4 | 600.2 | 596.5 | 575.7 | 669.0 | 533.5 | 431.3 | 355.4 | 318.4 | 283.3 | 301.3 | 126.3 | 86.6 | 62.1 | 42.9 | 51.8 | 43.1 | 37.8 | 33.3 | 25.4 | 25.1 | 17.4 | 8.2 |
| OPERATING INCOME | ||||||||||||||||||||||||||||
| Operating Expenses | 600.1 | 681.7 | 653.3 | 641.4 | 641.4 | 537.9 | 550.8 | 429.7 | 441.5 | 394.6 | 305.5 | 251.0 | 197.6 | 183.3 | 156.8 | 263.2 | 174.0 | 132.2 | 102.8 | 85.5 | 79.1 | 61.8 | 50.9 | 44.9 | 37.8 | 38.1 | 29.9 | 17.1 |
| Selling, General and Administrative Expenses | 514.7 | 599.8 | 500.7 | 555.5 | 555.5 | 467.1 | 476.4 | 359.1 | 366.0 | 327.1 | 251.8 | 208.4 | 169.8 | 161.4 | 138.9 | 123.5 | 73.3 | 48.5 | 43.6 | 34.8 | 31.5 | 25.5 | 17.1 | 13.5 | 11.1 | 11.8 | 8.8 | 2.5 |
| Research and Development Expenses | 85.4 | 81.9 | 80.9 | 85.9 | 85.9 | 70.8 | 74.4 | 70.6 | 75.5 | 67.5 | 53.7 | 42.6 | 27.8 | 21.9 | 17.9 | 139.7 | 100.7 | 83.8 | 59.2 | 50.7 | 47.6 | 36.3 | 33.8 | 28.1 | 23.5 | 23.0 | 18.6 | 13.0 |
| Operating Income | (123.7) | (48.7) | (194.8) | 7.6 | 7.6 | 118.7 | 49.4 | 166.8 | 134.2 | 274.4 | 228.0 | 180.3 | 157.8 | 135.1 | 126.5 | 38.1 | (47.7) | (45.6) | (40.7) | (42.6) | (27.3) | (18.7) | (13.1) | (11.5) | (12.4) | (13.0) | (12.5) | (8.9) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||||
| Interest Income Expense | 3.2 | 6.6 | 0 | 12.0 | 12.0 | 3.2 | 6.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (16.9) | (8.4) | (88.9) | 100 K | 100 K | 60.8 | (1.7) | 1.2 | 0.3 | (2.0) | (0.2) | (0.4) | (0.4) | 99 K | (2.5) | (3.3) | 0.7 | 12 K | (2.0) | 10 K | 38 K | (0.2) | (0.3) | (0.4) | 12.4 | 3.2 | 3.3 | 3.1 |
| Pre-Tax Income | (140.6) | (57.1) | (283.7) | 0.2 | 7.7 | 116.9 | 42.9 | 168.9 | 134.9 | 277.9 | 233.3 | 184.5 | 159.7 | 140.8 | 136.4 | 48.5 | (35.0) | (38.2) | (40.0) | (40.6) | (24.4) | (13.5) | (6.6) | (8.7) | (10.0) | (9.8) | (9.2) | (5.9) |
| NET INCOME | ||||||||||||||||||||||||||||
| Tax Provision | (28.6) | (29.9) | 59.9 | (4.4) | (4.4) | (13.9) | 21.3 | 43.6 | 54.7 | 101.6 | 86.1 | 72.4 | 58.9 | (11.5) | 0.2 | 0.6 | 35.0 | (7.4) | (0.8) | (2.0) | 0.4 | 0.5 | 0.6 | 8.7 | 10.0 | 9.8 | 9.2 | 5.9 |
| Net Income | (112.0) | (27.2) | (223.7) | 4.6 | 4.6 | 131.0 | 21.8 | 125.3 | 80.2 | 176.2 | 147.1 | 112.2 | 100.7 | 152.3 | 84.6 | 47.8 | (35.0) | (38.2) | (40.0) | (40.6) | (24.8) | (14.0) | (7.2) | (8.7) | (10.0) | (9.8) | (9.2) | (5.9) |
| EPS | 1.39 | 0.35 | 2.99 | 0.0626 | 0.06 | 1.89 | 0.32 | 1.79 | 1.12 | 2.33 | 1.82 | 1.33 | 1.12 | 1.58 | 0.91 | 0.54 | 0.43 | 0.53 | 0.65 | 0.74 | 0.48 | 0.3 | 0.16 | 0.22 | 0.27 | 0.26 | 0.26 | 0.2 |